Mupadolimab, a promising therapeutic, is generating significant interest within the scientific field due to its distinct mechanism of activity. This anti-CD73 compound specifically blocks CD73, a plasma protein https://bookmarks-hit.com/story26168939/a-promising-antibody-a-potential-cd73-blocking-antibody-demonstrates-hope